iFrame is not supported! Everolimus: Julie Gralow SABCS 2022 SWOG S1207 in HER2- Breast Cancer   What is Everolimus and how can it help patients with HR+ HER2-negative breast cancer? The SWOG S1207 was a trial in the adjuvant breast cancer setting for patients that have hormone receptor positive and HER two negative breast cancer … Continue reading Everolimus: Julie Gralow SABCS 2022 SWOG S1207 HER2- Breast Cancer